A controlled safety study of diindolylmethane in the immature rat model

Laryngoscope

Volumn 119, Issue 9, 2009, Pages 1803-1808

  Elackattu, Alphi P ^a   Feng, Lining ^a   Wang, Zhi ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b Department of Otolaryngology ^*  (United States)

Author keywords

Diindolylmethane; Rat; Safety; Sex immature

Indexed keywords

DIINDOLYLMETHANE; INDOLE DERIVATIVE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BODY WEIGHT; BONE DENSITOMETRY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HISTOLOGY; IMMATURITY; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; VITAMIN BLOOD LEVEL;

ANIMALS; BODY WEIGHT; FEASIBILITY STUDIES; INDOLES; KIDNEY; LARYNGEAL NEOPLASMS; LIVER; MODELS, ANIMAL; PAPILLOMA; PROSPECTIVE STUDIES; RATS; VITAMIN D;

EID: 70349586374     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20526     Document Type: Article

References (18)

1. Zeitels SM, Akst LM, Burns JA, et al. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol 2006;115:679-685.
2. Mouadeb DA, Belafsky PC. In-office laryngeal surgery with the 585 nm pulsed dye laser (PDL). Otolaryngol Head Neck Surg 2007;137:477-481.
3. Bielecki I, Mniszek J, Cofala M. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol 2009;73:681-684.
4. Bradfield CA, Bjeldanes JF. Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism. J Toxicol Environ Health 1987;21:311-322.
5. Bradlow HL. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer [review]. In Vivo 2008;22: 441-445.
6. Gong Y, Sohn H, Xue L, Firestone GL, Bjeldanes LF. 3, 3′- Diindolylmethane is a novel mitochondrial H(+)ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res 2006;66:4880-4887.
7. Zhao YY, Zhou L, Pan YZ, et al. 3, 3-diindolylmethane enhances the inhibitory effect of idarubicin on the growth of human prostate cancer cells [in Chinese]. Zhonghua Yi Xue Za Zhi 2008;88:661-664.
8. Chinnakannu K, Chen D, Li Y, et al. Cell cycle-dependent effects of 3, 3′-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J Cell Physiol 2009;219: 94-99.
9. Howells LM, Gallacher-Horley B, Houghton CE, et al. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol Cancer Ther 2002;1:1161-1172.
10. Gong Y, Firestone GL, Bjeldanes LF. 3, 3′-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells. Mol Pharmacol 2006;69: 1320-1327.
11. Degner SC, Papoutsis AJ, Selmin O, et al. Targeting of Aryl hydrocarbon receptor-mediated activation of cyclooxygenase- 2 expression by the indole-3-carbinol metabolite 3, 3- diindolylmethane in breast cancer cells. J Nutr 2009;139: 26-32.
12. Kassie F, Anderson LB, Scherber R, et al. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res 2007;67:6502-6511.
13. Newfield L, Goldsmith A, Bradlow HL, et al. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemoprophylaxis with indole-3-carbinol. Anticancer Res 1993;13:337-341.
14. Auborn K, Abramson A, Bradlow HL, et al. Estrogen metabolism and laryngeal papillomatosis: a pilot stud on dietary prevention. Anticancer Res 1998;18:4569-4573.
15. Leibelt D, Olaf RH, Hedstrom KA, et al. Evaluation of chronic dietary esposure to indole-3-carbinol and absorption- enhanced 3, 3-diindolylmethane in Sprague-Dawley rats. Toxicol Sci 2003;74:20-22.
16. Reed GA, Sunega JM, Sullivan DK, et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3, 3′- diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev 2008;17:2619-2624.
17. de Bilderling G, Bodart E, Lawson G, et al. Successful use of intralesional and intravenous Cidofovir in association with indole-3-carbinol in an 8 year-old girl with pulmonary papillomatosis. J Med Virol 2005;75:332-335.
18. Rosen CA, Woodson Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004;18:248-253.